In recent years we have been growing significantly, expanding our portfolio and hiring whole new teams of employees to meet the increasing demand for our products.
More
Fast and simultaneous detection of SARS-CoV-2 and typing of the two most dangerous vaccine-escape mutations E484K and N501Y in a single PCR reaction.
More
Like the previous year, in 2021 GeneProof will participate in the medical conference and exhibition Medlab Middle East.
More
On 1 March 2021 one of the first diagnostic products that can quickly identify the two most serious SARS-CoV-2 variants was launched by GeneProof, a Czech biotechnology company.…
More
The new strain of the SARS-CoV-2 coronavirus, which first appeared in southern England in late 2020, also known as the “British variant,” has quickly spread to other parts of the…
More
Our PCR kits from Sexually Transmitted Infections Panel successfully participated in QCMD 2020 Sexually Transmitted Infections, focused on differential diagnostics.
More
GeneProof as first Czech company given rights to supply COVID-19 kits to India.
More
Differential diagnostics of 5 pathogens from one sample in a single run
More
Our PCR COVID-19 test recommended in Algeria and Tunisia
More
Gregor Johann Mendel - Father of Genetics.
More